North Star Investment Management Corp. Biocryst Pharmaceuticals Inc Transaction History

North Star Investment Management Corp.

  • $1.35 Billion
  • Q2 2024

A detailed history of North Star Investment Management Corp. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, North Star Investment Management Corp. holds 200 shares of BCRX stock, worth $1,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$1,584
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$4.89 - $7.65 $977 - $1,530
200 New
200 $1,000
Q1 2023

Apr 27, 2023
SELL
$7.94 - $11.84 $2.76 Million - $4.11 Million
-347,300 Reduced 94.55%
20,000 $166,000
Q4 2022

Jan 11, 2023
SELL
$10.5 - $14.2 $783,300 - $1.06 Million
-74,600 Reduced 16.88%
367,300 $0
Q2 2022

Jul 19, 2022
SELL
$7.89 - $17.88 $11,835 - $26,820
-1,500 Reduced 0.34%
441,900 $4.68 Million
Q1 2022

May 03, 2022
SELL
$11.56 - $19.76 $73,984 - $126,464
-6,400 Reduced 1.42%
443,400 $7.21 Million
Q4 2021

Feb 07, 2022
BUY
$11.18 - $15.46 $77,142 - $106,674
6,900 Added 1.56%
449,800 $6.23 Million
Q3 2021

Oct 20, 2021
BUY
$14.21 - $17.65 $88,244 - $109,606
6,210 Added 1.42%
442,900 $6.36 Million
Q2 2021

Jul 13, 2021
BUY
$9.5 - $17.24 $8,550 - $15,515
900 Added 0.21%
436,690 $6.9 Million
Q1 2021

Apr 19, 2021
BUY
$7.37 - $13.61 $999,372 - $1.85 Million
135,600 Added 45.17%
435,790 $4.43 Million
Q4 2020

Jan 12, 2021
BUY
$3.37 - $8.61 $421,890 - $1.08 Million
125,190 Added 71.54%
300,190 $2.24 Million
Q3 2020

Oct 13, 2020
BUY
$3.43 - $5.53 $463,050 - $746,550
135,000 Added 337.5%
175,000 $601,000
Q2 2020

Jul 16, 2020
BUY
$1.9 - $5.61 $76,000 - $224,400
40,000 New
40,000 $191,000

Others Institutions Holding BCRX

# of Institutions
257
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.47B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email